Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 07/05/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/05/22 | 4 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 06/30/22 | 8-K | Current report filing |
|
   |
4 |
| 06/21/22 | 4 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 06/21/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/21/22 | 4 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 06/08/22 | 4 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 06/08/22 | 4 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 06/08/22 | 4 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 06/08/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
